Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

HIV Infection

Free Subscription 05.01.2026 19 AIDS 7 AIDS Res Hum Retroviruses 1 Ann Intern Med 1 Br J Dermatol 1 Br J Haematol 2 Clin Infect Dis 11 HIV Med 1 Int J Cancer 7 J Acquir Immune Defic Syndr 1 J Clin Invest 3 J Infect Dis 3 J Med Virol 1 J Virol 2 Lancet 1 Pediatr Infect Dis J 9 PLoS One 2 PLoS Pathog

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. YADAV A, Stephens-Shields AJ, Karaj A, Kossenkov AV, et al
   Galantamine for 12 weeks does not improve neurocognition or immune activation in ART-suppressed people with HIV.
   AIDS. 2025 Nov 28. doi: 10.1097/QAD.0000000000004418.
   PubMed         Abstract available
   
   
2. KUHN L, Brennan AT
   No cause for complacency regarding health of children who are HIV-exposed but uninfected.
   AIDS. 2026;40:249-251.
   PubMed        
   
   
3. WOOD BR
   Doravirine/islatravir for heavily treatment-experienced adults with HIV: promise interrupted.
   AIDS. 2026;40:252-253.
   PubMed        
   
   
4. WOOLLEY IJ
   Hyping up hypertension and HIV.
   AIDS. 2026;40:254-255.
   PubMed        
   
   
5. APOLIANO CF, de Oliveira ACS, Folgosi VA, Prates GS, et al
   Elevated sCD14 in cerebrospinal fluid: a surrogate marker for HIV-associated neurocognitive disorders in Brazil.
   AIDS. 2026;40:260-263.
   PubMed         Abstract available
   
   
6. MACBAIN E, Conroy AL, Brophy J, Kakkar F, et al
   Chitinase-3-like 1 is associated with stunting and developmental delay in HIV-exposed but uninfected Ugandan children.
   AIDS. 2026;40:263-266.
   PubMed         Abstract available
   
   
7. AGARAWAL S, Samanta J, Chauhan RS, Kathrani N, et al
   Paradoxical tuberculosis-immune reconstitution inflammatory response syndrome after antituberculous drug modification in HIV with dual central nervous system infections.
   AIDS. 2026;40:267-269.
   PubMed        
   
   
8. MARCELIN AG, Soulie C, Wirden M, Gruber J, et al
   Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens.
   AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004438.
   PubMed         Abstract available
   
   
9. WILLIAMS A, Adungo F, Ramirez JL, Oriol-Mathieu V, et al
   The role of subtyping methodologies in HIV surveillance and vaccine development: a systematic review and meta-analysis.
   AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004427.
   PubMed         Abstract available
   
   
10. MURNANE PM, Bukusi EA, Otieno P, Frongillo EA, et al
    Effects of an agricultural intervention on psychosocial health among pregnant and non-pregnant women with HIV in Kenya.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004436.
    PubMed         Abstract available
    
    
11. PLAISY MK, Mondoka C, Moreira R, Samala N, et al
    Diagnostic value of serological scores for the detection of liver steatosis in people living with HIV in low- and middle-income countries.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004434.
    PubMed         Abstract available
    
    
12. PADILLA S, Ledesma C, Fernandez-Gonzalez M, Perez-Calvo F, et al
    Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004437.
    PubMed         Abstract available
    
    
13. WILLEMSTEIN IJM, Prins M, Wijstma E, Van Sighem A, et al
    Estimating the HIV PrEP care continuum among gay, bisexual and other men who have sex with men in Amsterdam and the Netherlands, 2023.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004430.
    PubMed         Abstract available
    
    
14. SHILABYE PS, Scheuermaier K, Umunnakwe CN, Barth RE, et al
    HIV and ART status at baseline are associated longitudinally with increased pulse wave velocity: findings from the Ndlovu cohort study.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004428.
    PubMed         Abstract available
    
    
15. FLICK RJ, Masiano SP, Tembo TA, Sykes C, et al
    Novel application of DBS tenofovir diphosphate to predict viral suppression in postpartum women living with HIV in Malawi.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004433.
    PubMed         Abstract available
    
    
16. SCHEIER TC, De Gouveia K, Engel ME, Hohlfeld AS, et al
    One-year mortality among adults with advanced HIV in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004431.
    PubMed         Abstract available
    
    
17. SHENG Q, Olumefun S, Peter O, Akhigbe P, et al
    Cognitive performance in adolescents with perinatally-acquired HIV and associations with oral health in Nigeria.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004429.
    PubMed         Abstract available
    
    
18. BLANKENBERGER J, Devendra A, Bakaya M, Lee T, et al
    Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV (LoDoCA): a prospective cohort study in lesotho, Southern Africa.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004432.
    PubMed         Abstract available
    
    
19. ALAGARATNAM J, Bakewell N, Kunisaki KM, Mallon PWG, et al
    Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIV.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004435.
    PubMed         Abstract available
    
    

    
    AIDS Res Hum Retroviruses

20. AHMED A, Dong KL, Hussain M, Ngcobo MW, et al
    Psychological Impact of Analytical Treatment Interruption on Young Women Enrolled in an HIV Cure-Related Clinical Trial in Durban, South Africa.
    AIDS Res Hum Retroviruses. 2025 Dec 22. doi: 10.1177/08892229251405807.
    PubMed         Abstract available
    
    
21. ZHU Y, Liu J, Kang L, Ruan F, et al
    HCV Genotype Distribution and Molecular Characteristics of HCV Core Domain I in Persons Living with HIV and HCV from Yunnan Province, China.
    AIDS Res Hum Retroviruses. 2025 Dec 11. doi: 10.1177/08892229251405803.
    PubMed         Abstract available
    
    
22. BAVI M, Jalilian S, Bijanzadeh M, Nashibi R, et al
    Frequency of CCR5-Delta32, CCR2-64I, and SDF1-3'A Mutations in People with HIV Diagnoses and HIV Negative Participant in Khuzestan Province, Iran.
    AIDS Res Hum Retroviruses. 2025 Dec 23. doi: 10.1177/08892229251405792.
    PubMed         Abstract available
    
    
23. SABU P, Alex D, Ramalingam VV, Demosthenes JP, et al
    Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center.
    AIDS Res Hum Retroviruses. 2025 Dec 18. doi: 10.1177/08892229251405793.
    PubMed         Abstract available
    
    
24. CHEN M, Chen H, Ma Y, Jia M, et al
    Identification of a Novel HIV-1 Circulating Recombinant Form (CRF184_BC) Among Heterosexual Populations Along the China-Myanmar Border Region.
    AIDS Res Hum Retroviruses. 2025 Dec 22. doi: 10.1177/08892229251410288.
    PubMed         Abstract available
    
    
25. OURSLER KK, Sun YV, Lozano AJ, Xu K, et al
    Epigenetic Age Acceleration and Frailty Among People with HIV.
    AIDS Res Hum Retroviruses. 2025 Dec 26. doi: 10.1177/08892229251411059.
    PubMed         Abstract available
    
    
26. ZHU B, Wang X, Li H, Liu Y, et al
    Identification of a Novel HIV-1 Second-Generation Circulating Recombinant Form (CRF193_0107) Among MSM in Hebei Province, China.
    AIDS Res Hum Retroviruses. 2025 Dec 24. doi: 10.1177/08892229251409887.
    PubMed         Abstract available
    
    

    
    Ann Intern Med

27. COLSON AE, Crofoot GE, Ruane PJ, Ramgopal MN, et al
    Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study.
    Ann Intern Med. 2025 Dec 23. doi: 10.7326/ANNALS-25-01939.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

28. TROIN L, Adamski H, Rousset P, Poizeau F, et al
    Use of mogamulizumab in cutaneous T-cell lymphomas among people living with HIV: insights from a nationwide French cohort.
    Br J Dermatol. 2025 Dec 30:ljaf534. doi: 10.1093.
    PubMed        
    
    

    
    Br J Haematol

29. HUGUET M, Morgades M, Rivas-Delgado A, Bastos-Oreiro M, et al
    Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO.
    Br J Haematol. 2025 Dec 23. doi: 10.1111/bjh.70287.
    PubMed        
    
    

    
    Clin Infect Dis

30. OSUALA EC, Nkuhairwe IN, Letsoalo MP, Naidoo K, et al
    Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin.
    Clin Infect Dis. 2025 Dec 30:ciaf732. doi: 10.1093.
    PubMed         Abstract available
    
    
31. IGNACIO RB, Pagkas-Bather J, Gonsalves G, Gianella S, et al
    Why Americans are Dying Younger? NIH Is Not the Problem. Our Broken Healthcare Delivery Is.
    Clin Infect Dis. 2025 Dec 20:ciaf671. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

32. HYDE R, van Schaik P, Lawrence C, Forbes G, et al
    HIV testing in primary care in a low-prevalence area of Northeast England.
    HIV Med. 2025 Dec 31. doi: 10.1111/hiv.70189.
    PubMed         Abstract available
    
    
33. SUAREZ-GARCIA I, Alejos B, Moreno C, de Miguel R, et al
    Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.
    HIV Med. 2025 Dec 31. doi: 10.1111/hiv.70183.
    PubMed         Abstract available
    
    
34. DHAIRYAWAN R, Paparini S, Smuk M, Sidat S, et al
    Supporting long-term engagement in HIV clinical care: Learning from the COVID-19 pandemic.
    HIV Med. 2025 Dec 31. doi: 10.1111/hiv.70181.
    PubMed         Abstract available
    
    
35. SEZER B, Aydogdu T, Ata B
    Knowledge and attitudes toward HIV/AIDS among Turkish clinical medical and dental students.
    HIV Med. 2025 Dec 30. doi: 10.1111/hiv.70146.
    PubMed         Abstract available
    
    
36. BAUCHER E, Gilles C, Manigart Y, Barlow P, et al
    Risk factors, management, and HPV genotyping of vulvar intraepithelial neoplasia (VIN) in women living with HIV: A comparison with women without HIV and a case control study.
    HIV Med. 2025 Dec 30. doi: 10.1111/hiv.70184.
    PubMed         Abstract available
    
    
37. KOKORELIAS KM, Rochon P, Zhabokritsky A, Walmsley SL, et al
    Midlife and beyond: Integrating menopause and cervical screening for women and gender-diverse people living with HIV.
    HIV Med. 2025 Dec 25. doi: 10.1111/hiv.70186.
    PubMed        
    
    
38. MAZZITELLI M, Boffito M, Torti C
    Review on: Polypharmacy in HIV: Rethinking what counts and why it matters.
    HIV Med. 2025 Dec 25. doi: 10.1111/hiv.70185.
    PubMed        
    
    
39. PORCHIA DD, Wang Y, Zhou Z, Chen M, et al
    Cannabis use, microbial diversity and Dialister abundance in older adults with HIV: A cross-sectional study.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70180.
    PubMed         Abstract available
    
    
40. GOZLAN Y, Wertheim JO, Mor O, Elbirt D, et al
    Deciphering HIV-1 transmission in young adults: Phylogenetic analysis reveals varied histories and an elite controller.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70182.
    PubMed         Abstract available
    
    
41. MAZZITELLI M, Purusothman P, Calandrino L, Suchak T, et al
    HIV diagnosis and treatment outcomes in cis- and trans-gender women across two European centres: A comparative observational study.
    HIV Med. 2025 Dec 21. doi: 10.1111/hiv.70160.
    PubMed         Abstract available
    
    
42. HIRANBURANA N, Sophonphan J, Kerr SJ, Lertpiriyasuwat C, et al
    Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis.
    HIV Med. 2025 Dec 19. doi: 10.1111/hiv.70178.
    PubMed         Abstract available
    
    

    
    Int J Cancer

43. HADJI M, Rashidian H, Marzban M, Rezaianzadeh A, et al
    The association between waterpipe smoking and head and neck squamous cell carcinoma: A multicenter case-control study in Iran.
    Int J Cancer. 2025 Dec 26. doi: 10.1002/ijc.70258.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

44. BALTRUSAITIS K, Tierney C, Fowler MG, Owor M, et al
    Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trial.
    J Acquir Immune Defic Syndr. 2025 Dec 31. doi: 10.1097/QAI.0000000000003829.
    PubMed         Abstract available
    
    
45. RUDERMAN SA, Fahey CA, Delaney JA, Kyle R, et al
    Frailty and All-Cause Mortality among People with HIV Engaged in Clinical Care in the United States.
    J Acquir Immune Defic Syndr. 2025 Dec 26. doi: 10.1097/QAI.0000000000003826.
    PubMed         Abstract available
    
    
46. KANG M, Umbleja T, Avihingsanon A, Cardoso SW, et al
    Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.
    J Acquir Immune Defic Syndr. 2025 Dec 26:10.1097/QAI.0000000000003828.
    PubMed         Abstract available
    
    
47. APORNPONG T, Do TC, Han WM, Hiranburana N, et al
    Letter to the Editor Burden of Pre-Frailty and Frailty in older People with and without HIV in Thailand.
    J Acquir Immune Defic Syndr. 2025 Dec 26. doi: 10.1097/QAI.0000000000003827.
    PubMed        
    
    
48. SERTI E, Bartolanzo D, Frndak S, Owuoth J, et al
    Loss to Follow up and Visit Non-Adherence in an HIV Incidence Cohort in Kisumu, Kenya.
    J Acquir Immune Defic Syndr. 2025 Dec 26. doi: 10.1097/QAI.0000000000003825.
    PubMed         Abstract available
    
    
49. SELZER L, Cai A, Poosarla A, Li J, et al
    Association of HIV Envelope Susceptibility Signatures to Broadly Neutralizing Antibodies and Presence of p24 CTL Epitopes During Acute HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2025 Dec 22. doi: 10.1097/QAI.0000000000003821.
    PubMed         Abstract available
    
    
50. WALKER CF, Lee MT, Chen PL, Ridgeway K, et al
    Real-World Estimates of HIV Incidence from Sexual Health Clinic EMRs: Feasibility, Limitations, and Implications for Surveillance.
    J Acquir Immune Defic Syndr. 2025 Dec 22. doi: 10.1097/QAI.0000000000003824.
    PubMed         Abstract available
    
    

    
    J Clin Invest

51. PETERSON JJ, Chandel S, James K, Bennett ES, et al
    Single cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypes.
    J Clin Invest. 2025 Dec 23:e196536. doi: 10.1172/JCI196536.
    PubMed         Abstract available
    
    

    
    J Infect Dis

52. IGNACIO RB, Pagkas-Bather J, Gonsalves G, Gianella S, et al
    Why Americans are Dying Younger? NIH Is Not the Problem. Our Broken Healthcare Delivery Is.
    J Infect Dis. 2025 Dec 20:jiaf592. doi: 10.1093.
    PubMed         Abstract available
    
    
53. MCCARTHY WJ, Ferguson F, Gelberg L
    For Optimal HIV Viral Load Reduction, Increase Intake of Gut Microbe-Friendly Foods: Comment on Palar et al.
    J Infect Dis. 2025;232:e1060-e1061.
    PubMed        
    
    
54. ANJUM SH, Hargarten J, Dulek B, Otaizo-Carrasquero F, et al
    Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis.
    J Infect Dis. 2025 Dec 25:jiaf653. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

55. XIAO J, Wang F, Zhu L, Liu Y, et al
    Residual Exhaustion of Stem Cell-Like Memory T Cells (T(SCM)) in HIV Infected Patients With Viral Suppression.
    J Med Virol. 2025;97:e70761.
    PubMed         Abstract available
    
    
56. EL KHALILI O, Chenwi CA, Spalletta D, Marchegiani G, et al
    Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid.
    J Med Virol. 2026;98:e70773.
    PubMed         Abstract available
    
    
57. LAGI F, Formica G, Fabbiani M, Rossetti B, et al
    Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV).
    J Med Virol. 2026;98:e70779.
    PubMed         Abstract available
    
    

    
    J Virol

58. KREIG JAF, Wahl A, Fernandes E, Honeycutt JB, et al
    The decay of HIV under anti-retroviral therapy is biphasic even in humanized mice with just T cells.
    J Virol. 2025 Dec 30:e0132125. doi: 10.1128/jvi.01321.
    PubMed         Abstract available
    
    

    
    Lancet

59. GREEN A
    Botswana's HIV services struggle.
    Lancet. 2025 Dec 17:S0140-6736(25)02585-1. doi: 10.1016/S0140-6736(25)02585.
    PubMed        
    
    
60. VAKANIAKI EH, Barhishindi I, Mubiala A, Malembaka EB, et al
    Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study.
    Lancet. 2025 Dec 19:S0140-6736(25)02309-8. doi: 10.1016/S0140-6736(25)02309.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

61. HUYNH J, Le NHT, Le Nguyen BH, Hoang HT, et al
    The Utility of a Three-gene Host Response to Discriminate Tuberculous Meningitis From Other Infections in Children.
    Pediatr Infect Dis J. 2025 Dec 23. doi: 10.1097/INF.0000000000005105.
    PubMed         Abstract available
    
    

    
    PLoS One

62. MALLYA SP, Mbelele PM, Kisonga RM, Mtunga DD, et al
    Diagnostic accuracy of the TrueNat MTB plus assay for detecting pulmonary tuberculosis in adults.
    PLoS One. 2025;20:e0327936.
    PubMed         Abstract available
    
    
63. BUKHARBAYEVA A, Davis A, Rosenthal SL, Myrkassymova A, et al
    Factors associated with perceived weight gain among the adult population of Kazakhstan during the COVID-19 pandemic.
    PLoS One. 2025;20:e0339619.
    PubMed         Abstract available
    
    
64. WANG X, An X, Zhao H, Sun D, et al
    Characteristics of spatiotemporal distribution of HIV-1 Gag-containing complexes on the dorsal membrane tracking with live confocal imaging.
    PLoS One. 2025;20:e0339593.
    PubMed         Abstract available
    
    
65. OGUNBAJO A, Sotubo O, Okanlawon K, Shoyemi E, et al
    Intersectional stigma and adherence to antiretroviral (ART) among sexual minority men (SMM) living with HIV in Nigeria: A Qualitative Inquiry.
    PLoS One. 2025;20:e0338933.
    PubMed         Abstract available
    
    
66. KHANDU L, Hallett J, Crawford G, Leavy JE, et al
    HIV self-testing and partner notification strategies for key populations in low- to upper-middle-income countries: A mixed-methods systematic review.
    PLoS One. 2025;20:e0338639.
    PubMed         Abstract available
    
    
67. TAO J, Gu M, Marshall SA, Baloh J, et al
    Engagement and retention in HIV care in rural Southern U.S. using an All-Payer Claims Database.
    PLoS One. 2025;20:e0339520.
    PubMed         Abstract available
    
    
68. MARIANA N, Gayatri A, Widyahening IS, Bela B, et al
    The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia.
    PLoS One. 2025;20:e0336210.
    PubMed         Abstract available
    
    
69. KIRICHENKO A, Kireev D, Lopatukhin A, Murzakova A, et al
    Correction: Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
    PLoS One. 2026;21:e0340124.
    PubMed         Abstract available
    
    
70. DADI TA, Bedada TT, Akako AD, Wodajo LT, et al
    Impaired estimated glomerular filtration rate and associated factors among adult patients living with HIV at Asella Referral and Teaching Hospital, Ethiopia: A cross-sectional study.
    PLoS One. 2026;21:e0330238.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

71. YAO L, Gao Y, Tian W, Ding H, et al
    Broadly neutralizing antibody responses in a Chinese acute HIV-1 infection cohort of men who have sex with men.
    PLoS Pathog. 2026;22:e1013822.
    PubMed         Abstract available
    
    
72. MCGEE K, Dowell A, Lauder S, Begum J, et al
    Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study.
    PLoS Pathog. 2025;21:e1013803.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.